Need an oil spill lawyer? We will fight for you!
› $150,000,000 verdict in personal injury case
Much has been reported lately about chondrolysis of the shoulder, or Postarthroscopic Glenohumeral Chondrolysis (PAGCL). So what is chondrolysis and why is it getting so much face time? Chondrolysis is the destruction of the cartilage in a joint. It is generally a rare condition anywhere in the body, but it has been most often heard of in hip joints most often from birth defects. Before the 1990s, chondrolysis in the shoulder was never seen.
Patients who used pain pump devices to relieve pain from shoulder surgery are at risk for permanent joint damage, according to recent studies. Pain pumps are balloon-like devices that are filled with anesthetics that deliver medication directly into the surgical space via a catheter. The medication is slowly released into the joint space for up to 72 hours following surgery and then the catheter is removed by the patient.
While this use of pain pumps was a convenient way to relieve pain from surgery, it also resulted in a surprisingly high number of cases of a painful and debilitating deterioration of cartilage in the shoulder joint known as chondrolysis, specifically Postarthroscopic Glenhumeral Chondrolysis (PAGCL). The condition is permanent and many who suffer from it require shoulder replacement surgery.
The Food and Drug Administration (FDA) is notifying health care professionals of reports of a serious and destructive cartilage condition known as chondrolysis in patients who have had shoulder surgery during which they received continuously infused local anesthetics to deaden pain. The anesthetics were delivered via pain pumps, balloon-like devices that hold medication outside the body and have a catheter that delivers pain medication directly into the shoulder joint for up to 72 hours following surgery.
Patients who have had an orthopedic surgical procedure and received a prolonged infusion of a local anesthetic into the joint with a disposable elastomeric pump or any other infusion pump are urged by the Food and Drug Administration (FDA) to pay attention to symptoms of any joint pain, stiffness and decrease or loss of motion. If any of those symptoms persist, patients are advised to contact their health care professional.
![[ Beasley Allen Law Firm Logo ]](http://www.painpump.net/wp-content/themes/system-unity/images/logo.png){kind=logo}